Unknown

Dataset Information

0

Zoledronic Acid in a Mouse Model of Human Fibrous Dysplasia: Ineffectiveness on Tissue Pathology, Formation of "Giant Osteoclasts" and Pathogenetic Implications.


ABSTRACT: We compared the effects of a nitrogen-containing bisphosphonate (N-BP), zoledronic acid (ZA), and an anti-mouse RANKL antibody (anti-mRANKL Ab) on the bone tissue pathology of a transgenic mouse model of human fibrous dysplasia (FD). For comparison, we also reviewed the histological samples of a child with McCune-Albright syndrome (MAS) treated with Pamidronate for 3 years. EF1?-Gs?R201C mice with FD-like lesions in the tail vertebrae were treated with either 0.2 mg/kg of ZA at day 0, 7, and 14 or with 300 ?g/mouse of anti-mRANKL Ab at day 0 and 21. All mice were monitored by Faxitron and histological analysis was performed at day 42. ZA did not affect the progression of the radiographic phenotype in EF1?-Gs?R201C mice. FD-like lesions in the ZA group showed the persistence of osteoclasts, easily detectable osteoclast apoptotic activity and numerous "giant osteoclasts". In contrast, in the anti-mRANKL Ab-treated mice, osteoclasts were markedly reduced/absent, the radiographic phenotype reverted and the FD-like lesions were extensively replaced by newly formed bone. Numerous "giant osteoclasts" were also detected in the samples of the child with MAS. This study supports the hypothesis that osteoclasts per se, independently of their resorptive activity, are essential for development and expansion of FD lesions.

SUBMITTER: Corsi A 

PROVIDER: S-EPMC7593313 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Zoledronic Acid in a Mouse Model of Human Fibrous Dysplasia: Ineffectiveness on Tissue Pathology, Formation of "Giant Osteoclasts" and Pathogenetic Implications.

Corsi Alessandro A   Palmisano Biagio B   Spica Emanuela E   Di Filippo Annamaria A   Coletta Ilenia I   Dello Spedale Venti Michele M   Labella Rossella R   Fabretti Francesca F   Donsante Samantha S   Remoli Cristina C   Serafini Marta M   Riminucci Mara M  

Calcified tissue international 20200901 6


We compared the effects of a nitrogen-containing bisphosphonate (N-BP), zoledronic acid (ZA), and an anti-mouse RANKL antibody (anti-mRANKL Ab) on the bone tissue pathology of a transgenic mouse model of human fibrous dysplasia (FD). For comparison, we also reviewed the histological samples of a child with McCune-Albright syndrome (MAS) treated with Pamidronate for 3 years. EF1α-Gsα<sup>R201C</sup> mice with FD-like lesions in the tail vertebrae were treated with either 0.2 mg/kg of ZA at day 0,  ...[more]

Similar Datasets

| S-EPMC4107035 | biostudies-literature
| S-EPMC3377825 | biostudies-literature
| S-EPMC6218312 | biostudies-literature
| S-EPMC7448291 | biostudies-literature
| S-EPMC7657394 | biostudies-literature
| S-EPMC8684721 | biostudies-literature
| S-EPMC3669677 | biostudies-literature
| S-EPMC7497813 | biostudies-literature
2024-01-15 | GSE250357 | GEO
| S-EPMC2782613 | biostudies-literature